SNB Capital started its coverage of Dallah Healthcare Co. (Dallah Health) with a “Neutral” recommendation and a target price of SAR 156.80 p
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Most Read